IL1B and Alzheimer disease: Craft et al. (2005) reported that IL-1 receptor antagonist knockout mice, which have enhanced IL-1 signaling, show increased vulnerability to Aβ-related toxicity, suggesting that enhanced neuroinflammation mediated by IL-1 could have an unfavorable effect on the AD brain.